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PURPOSE. The purpose of this study was to evaluate the rate of visual field (VF) loss in primary
open-angle glaucoma (POAG) and primary angle-closure glaucoma (PACG).
METHODS. Four hundred forty eyes of 282 patients with POAG (aged 53.4 6 12.0: mean 6
standard deviation, years) and 79 eyes of 49 patients with PACG (aged 62.7 6 9.0 years) with
at least six or more reliable VF tests were studied. Point-wise, region-wise, and global rates of
VF change were assessed for POAG and PACG eyes. Only the VF records prior to laser
iridotomy or cataract surgery were included in PACG eyes. The global and superior-inferior
asymmetric rates of VF loss were compared between POAG and PACG eyes.
RESULTS. The mean total deviation (mTD) values at baseline were 6.4 6 5.7 dB in POAG
patients and 6.4 6 7.3 dB in PACG patients. There was not a significant difference in the
progression rates of mTD between POAG eyes (0.23 6 0.38 dB/y) and PACG eyes (0.29 6
0.45 dB/y). In POAG eyes, the VF progression rate was significantly asymmetric across the
horizontal line; the central, paracentral, and peripheral arcuate 2 regions in the superior
hemifield had a significantly faster rate of VF loss than their inferior counterparts. In contrast,
this asymmetry was not observed in the rate of VF loss in PACG eyes.
CONCLUSIONS. POAG eyes showed a faster rate of VF loss in the superior hemifield compared to
in the inferior hemifield, particularly in central and paracentral regions. This difference was
not observed in PACG eyes.
Keywords: primary angle-closure glaucoma, primary open-angle glaucoma, visual field,
progression rate
Glaucoma is one of the leading causes of blindnessworldwide.1–3 There are two types of primary glaucoma:
primary open-angle glaucoma (POAG) and primary angle-
closure glaucoma (PACG). POAG is characterized by an open
iridocorneal angle, and in contrast, PACG is characterized by a
narrow or closed iridocorneal angle that hampers the aqueous
efflux, which can lead to increased IOP.
POAG predominates over PACG in most populations, with a
prevalence of 3.54% in those between 40 and 80 years old.4
The prevalence is approximately 0.92% in PACG.2 In contrast to
the higher prevalence of POAG, PACG has a threefold greater
risk of developing blindness compared to POAG.4–8 As a result,
it is estimated that 4.5 million people worldwide are bilaterally
blind due to POAG, whereas that number is 3.9 million people
with PACG.2 This is problematic, particularly in areas where
there is a high prevalence of PACG such as in in Alaska (among
those of Eskimo descent9), Asia,4,9 Myanmar,10 and Mongo-
lia.11,12
The clinical courses of POAG and PACG are very different. It
has been well documented that IOP is the major risk factor for
POAG. However, there are other risk factors, including older
age, disc hemorrhage, large cup-to-disc ratio, beta-zone para-
papillary atrophy, and lower systemic blood pressure.13–24 On
the other hand, in PACG, the elevation of IOP due to angle
closure is usually the exclusive disease mechanism.12 This
difference in disease mechanisms is also supported by genetic
findings of different single nucleotide polymorphism associa-
tions in PACG and POAG.25,26
Previous studies have reported that POAG and PACG have
different patterns in visual field (VF) damage.27–31 The VF
damage is more pronounced in the superior hemifield than in
the inferior hemifield in both POAG and PACG groups32–35;
however, this tendency is more obvious in POAG eyes.27–30
Without doubt, the assessment of the rate of VF loss is very
important in the management of glaucoma.Nonetheless, most
of the previous studies have investigated the cross-sectional
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spatial patterns of VF loss. However, a recent study has
investigated the rates of VF loss in eyes with PACG.36 It has
been reported in some of the population-based studies that the
rate of glaucoma-induced blindness is greater in eyes with
PACG compared to eyes with POAG. This might suggest that
the progression course in eyes with PACG is more aggressive
than eyes with POAG. To the best of our knowledge, there has
been no study comparing the progression rates and the
hemifield asymmetry of the rate of VF loss in POAG and PACG
eyes.
The purpose of the current study was to determine and
compare global, region-wise, and point-wise rates of VF loss in
POAG and PACG eyes to identify whether POAG and PACG
eyes progress at different rates and or with different patterns.
METHODS
Subjects
The review board of both institutes of Tokyo University
Hospital and Ryukyus University Hospital reviewed and
approved the study protocol. This study complied with the
tenets of the Declaration of Helsinki. Written consent was
given by each patient for their information to be stored in the
hospital database and used for research based on the
regulations of the Japanese Guidelines for Epidemiologic Study
2008 from the Ministry of Education, C., Sports, Science and
Technology.
VF tests were retrospectively acquired from the electronic
medical records of patients who visited either the Tokyo
University Hospital or Ryukyus University Hospital between
1998 and 2016. All patients with POAG and PACG who met the
criteria below were included: (1) glaucoma was the only
disease causing VF damage, (2) at least six VF measurements
were taken with 24-2 or 30-2 Humphrey Field Analyzer II (HFA)
(Carl Zeiss Meditec, Inc., Dublin, CA, USA) using the Swedish
Interactive Threshold Algorithm standard program, (3) an
abnormal VF defined with the Anderson-Patella criteria,37 (4)
20 years or older, and (5) secondary ocular hypertension in
either eye other than angle closure.
POAG was defined as (1) presence of typical glaucomatous
changes in the optic nerve head, including a rim notch with
rim width 0.1 disc diameters or a vertical cup-to-disc ratio
greater than 0.7 and/or a retinal nerve fiber layer defect with its
width at the optic nerve head margin greater than a major
retinal vessel, diverging in an arcuate or wedge shape, and (2)
wide open angle with gonioscopy. POAG eyes with significant
cataract were carefully excluded, except for clinically insignif-
icant senile cataract on biomicroscopy.
PACG was defined as (1) presence of angle closure defined
as at least 1808 of the posterior pigmented trabecular
meshwork not visible on gonioscopy in the primary position
of gaze without indentation and (2) existence of glaucomatous
optic neuropathy defined as neuroretinal rim loss with a
vertical cup-to-disc ratio of greater than 0.7 or between eye
vertical cup-to-disc ratio asymmetry of greater than 0.2, focal
notching of the neuroretinal rim with a VF defect suggestive of
glaucoma, or both.38 Eyes with significant cataract were
carefully excluded, except for clinically insignificant senile
cataract on biomicroscopy. Those with a history of an acute
primary angle closure attack were excluded. Only the VF
records prior to laser iridotomy or cataract surgery were
included for analysis with the PACG eyes. This is because VF
progression rate would be different between before and after
laser iridotomy (LI)/cataract surgery, whereas the principal
purpose of the current study was to investigate whether the
difference of disease mechanisms between POAG and PACG
yields difference in the VF progression rates between POAG
and PACG eyes.
Visual Fields
Reliable VF tests with less than 33% fixation losses and less
than 15% false-positive results were included, as recommended
by the manufacturer. The first VF records were excluded to
reduce learning effects. VFs with a 30-2 test pattern were
matched to 24-2 test patterns by using only the 52 overlapping
test locations. The mean of the 52 total deviation (TD; mTD)
values was calculated.
For both POAG and PACG groups, longitudinal VFs were
stratified into groups of six (first six VFs) to 10 visits (first 10
VFs). The entire VF was divided into 10 spatial regions by
allocating five regions both in the superior and inferior
hemifields following the Glaucoma Hemifield Test (GHT)28,39:
central, paracentral, nasal, arcuate 1, and arcuate 2 regions
(Fig. 1).
The mean values of TD in each of the 10 regions was
calculated by averaging the TD values of all test locations
included in the region.
Statistical Analysis
Processes. We first investigated the overall rate of VF loss
in POAG and PACG eyes. We then assessed the superior-inferior
asymmetry in the rate of VF loss in POAG and PACG eyes. This
was performed by comparing the rates of VF loss of the
superior and inferior hemifields in both a point-wise and a
region-wise manner. The rate of VF loss was calculated based
on various VF sequences lengths (from 6 to 10 VFs) using a
linear regression model. Subsequently, the asymmetry in the
rate of VF loss between superior and inferior hemifields was
investigated for each sequence length (Fig. 2).
Within-Group Comparisons. This comparison was per-
formed for POAG and PACG groups region-wise and point-wise,
separately. The analyses were conducted using (1) the rates of
VF loss calculated from VF sequences of 6 to 10 visits (as
shown in Fig. 2) and also (2) the rate of VF loss calculated from
VF sequences with all visits. The significance of the superior-
inferior asymmetry in the rate of VF loss was compared using
the Generalized Estimating Equation (GEE)40 to account for the
nested structure of the analyzed data, since the current study
included both left and right eyes of patients. More specifically,
FIGURE 1. GHT VF regions. Five GHT regions were allocated both in
the superior and inferior hemifields.
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for POAG (alternatively, PACG) eyes, the rates of VF loss were
calculated from VF sequences, and GEE models were fitted to
the rates of VF loss in the superior and inferior hemifields. The
outcome variables (rates of VF loss) were then compared
between the superior and inferior hemifields. Thus, we
conducted eight separate analyses: (1) POAG group at GHT
regions using VF sequences of 6 to 10 visits, (2) POAG group at
GHT regions using VF sequences with all visits, (3) POAG
group at each VF test point using VF sequences of 6 to 10
visits, (4) POAG group at each VF test point using VF
sequences with all visits, (5) PACG group at GHT regions
using VF sequences of 6 to 10 visits, (6) PACG group at GHT
regions using VF sequences with all visits, (7) PACG group at
each VF test point using VF sequences of 6 to 10 visits, and (8)
PACG group at each VF test point using VF sequences with all
visits.
Between-Group Comparisons. This comparison was
performed in GHT regions and test points using the asymmetry
in the rates of VF loss calculated from VF sequences of 6 to 10
visits (as shown in Fig. 2) and as well as the asymmetry in the
rate of VF loss calculated from VF sequences with all visits.
More specifically, the statistical difference between the extent
of asymmetry in the rates of VF loss (the difference between
the rates of VF loss in the superior and inferior hemifields)
between POAG and PACG groups was carried out by
constructing region-wise GEE models (alternatively, point-wise
models) where the outcome variable was the asymmetry in the
rate of VF loss and the primary independent variable was
diagnosis (POAG or PACG) controlling for gender, visual acuity,
length of follow-up, maximum IOP, and refractive error. Thus
we carried out two separate analyses: (1) extent of asymmetry
in the rates of VF loss at GHT regions using VF sequences with
of 6 to 10 visits and (2) extent of asymmetry in the rates of VF
loss at GHT regions using VF sequences with all visits.
Between-Group Comparison Subanalyses. As the num-
ber of eyes, the length of follow-up, and age were significantly
different between the POAG and PACG groups, we resampled
the eyes in each of POAG and PACG groups, requiring that the
difference between the length of follow-up and age be less
than 2 and 9 years, respectively. Using this new subset, the
between-group comparisons were repeated to confirm the
reproducibility of the outcome.
The demographics of the groups were compared using the
GEE model with the Gaussian function for continuous variables
and the binomial function for categorical variables, except for
age and gender, where the comparisons were made in patient
level. All statistical analyses were performed using the
statistical programming language R (R version 3.3.1; available
free of charge from The Foundation for Statistical Computing,
Vienna, Austria, https://www.r-project.org/).
RESULTS
Demographic characteristics of POAG and PACG eyes are
shown in the Table.
The POAG and PACG patients were similar in baseline mTD
values (P ¼ 0.88, GEE model), but the PACG patients were
significantly older than POAG patients (62.7 vs. 53.4 years, P <
0.001, GEE model) and had a higher proportion of females
compared to the POAG group (61.0% versus 50.0%, P¼ 0.067,
GEE model). The POAG patients had a greater maximum IOP
FIGURE 2. A flowchart showing the investigation of the superior-
inferior asymmetry in the rate of VF loss. The superior-inferior
asymmetry in the rate of VF loss was calculated by comparing the
GHT regions in the superior and inferior hemifields using rates
calculated from VF sequences of 6 to 10 visits. The black areas indicate
a statistically significant difference (P < 0.05) between the rate of VF
loss in the superior and inferior hemifields in that region.
TABLE. Demographic Information of Patients
Characteristics POAG PACG P
Subjects 282 49 –
Number of eyes total 440 79 –
Number of eyes at various VF series length, follow-up:
6 visits, y (mean 6 SD) 440 (2.4 6 0.7) 79 (3.7 6 1.7) <0.001*
7 visits, y (mean 6 SD) 439 (3.0 6 0.9) 61 (4.3 6 1.7) <0.001*
8 visits, y (mean 6 SD) 432 (3.6 6 1.0) 47 (5.1 6 1.9) <0.001*
9 visits, y (mean 6 SD) 430 (4.3 6 1.0) 41 (6.0 6 2.1) <0.001*
10 visits, y (mean 6 SD) 424 (4.9 6 11) 33 (6.7 6 1.6) <0.001*
Age, y 53.4 (12.0) 62.7 (9.0) <0.001*
Sex, %female 50.0% 61.0% 0.052
BCVA, logMAR 0.07 (0.08) 0.01 (0.09) <0.001*
Follow-up of all visits, y 7.6 (1.8) 7.1 (3.5) 0.13
mTD at the baseline, dB 6.4 (5.7) 6.4 (7.3) 0.88
mTD at the superior hemifield, baseline, dB 7.9 (8.5) 6.6 (8.1) 0.20
mTD at the inferior hemifield, baseline, dB 5.1 (5.7) 6.4 (8.0) 0.25
Max IOP, mm Hg 16.0 (2.8) 14.0 (3.2) 0.03*
Refractive error, diopters 4.4 (3.9) 0.38 (1.7) <0.001*
BCVA, best-corrected visual acuity.
* P values for the comparisons of follow-up length.
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compared to the PACG eyes (16.0 compared to 14.0, P¼0.038,
GEE model) and had a significantly better visual acuity than
PACG eyes (P < 0.001, GEE model). The refractive error of the
POAG eyes was significantly more myopic than PACG eyes (P <
0.001, GEE model). The length of follow-up was similar in
POAG and PACG patients (7.6 vs. 7.1 years, respectively, P ¼
0.13, GEE model).
Figure 3 shows the global rate of VF (mTD) loss in POAG
and PACG eyes with different number of VF sequences (from 6
to 10). PACG eyes had a consistenly faster global rate of VF loss
compared to POAG eyes; however, this difference was not
statistically significant in any number of VF sequences (P ¼
0.39, 0.13, 0.29, 0.17, and 0.48, with 6, 7, 8, 9, and 10 VFs,
respectively, GEE model). The global rate of VF (mTD) loss was
0.29 (SD ¼ 0.45) dB/y in the PACG group and 0.23 (SD ¼
0.38) dB/y in POAG group, calculated using VF sequences with
all available visits for each eye.
Figure 4 represents the cumulative density function of the
global rate of VF (mTD) loss in POAG and PACG eyes;
approximately 40% of the POAG eyes and 60% of the PACG
eyes had an mTD progression rate equal to or faster than0.25
dB/y, and approximately 20% of the eyes, in both PAOG and
PACG groups, had an mTD progression rate equal to or faster
than 0.50 dB/y.
Within-Group Analyses
Region-wise. Figure 5 demonstrates the region-wise
superior-inferior asymmetry in the rate of VF loss in POAG
(top panels) and PACG eyes (bottom panels) using VF
sequences of 6 to 10 visits. In eyes with POAG, there was a
significant asymmetry in the GHT central and paracentral
regions; that is, GHT central and paracentral regions in the
superior hemifield had significantly faster rates of VF loss
compared to their counterparts in the inferior hemifield (P ¼
0.01 and P ¼ 0.03, respectively). However, only GHT central
region in the superior hemifield had significantly faster rates of
VF loss than inferior hemifield after adjusting for multiple
observations using Bonferroni correction. In contrast, in eyes
with PACG, there was no significant asymmetry in the rate of
VF loss in any GHT region.
Figure 6 shows the region-wise superior-inferior asymmetry
in the rate of VF loss in eyes with POAG (left panel) and PACG
(right panel) using VF sequences with all visits. In POAG,
significant superior-inferior asymmetry in the rate of VF loss
(faster rate of VF loss in the superior hemifield than in the
inferior hemifield) was observed in the central and peripheral
arcuate 2 regions (P ¼ 0.04 and P ¼ 0.01 in the GEE model,
respectively). On the other hand, there was no asymmetry in
the rates of VF loss in PACG eyes.
Point-wise. Figure 7 shows the point-wise superior-inferior
asymmetry in the rate of VF loss in eyes with POAG (top panel)
and PACG (bottom panel) using VF sequences of 6 to 10 visits.
In POAG, significant superior-inferior asymmetry in the rate of
VF loss (faster progression rate in the superior hemifield than
the inferior hemifield) was observed more frequently in test
points located in the central, paracentral, temporal, and
FIGURE 3. Global rates of VF (mTD) loss in POAG and PACG eyes at
various VF series lengths. PACG eyes had a consistently faster
progression rate of mTD compared to POAG eyes; however, this
difference was not statistically significant in any VF series length. The
overal mTD progression rate was0.29 (SD¼ 0.45) dB/y in PACG eyes
and0.23 (SD¼ 0.38) dB/y in POAG group.
FIGURE 4. Cumulative density function of the progression rate of mTD in POAG and PACG eyes. Approximately 40% of the POAG eyes and 60% of
the PACG eyes had a mTD progression rate equal to or faster than0.25 dB/y, and approximately 20% of the eyes both in POAG and PACG groups
had a mTD progression rate equal to or faster than 0.50 dB/y.
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arcuate 2 regions. This asymmetry remained significant for the
test points in central, paracentral, and arcuate 2 regions in the
superior hemifield after adjusting for multiple observations
using Bonferroni correction. On the other hand, there was no
test point with significant superior-inferior asymmetry in the
rate of VF loss in PACG eyes.
Figure 8 shows the point-wise superior-inferior asymmetry
in the rate of VF loss in eyes with POAG (left panel) and PACG
(right panel) using VF sequences with all visits. In POAG,
significant superior-inferior asymmetry in the rate of VF loss
(faster rate of VF loss in the superior hemifield than the inferior
hemifield) was observed in the central, and peripheral arcuate
2 regions. On the other hand, there was no asymmetry in the
rates of VF loss in PACG eyes.
Between-Group Comparison (Extent of
Asymmetry in POAG Versus PACG)
Using VF Sequences of Length 6 to 10. To identify the
extent of the asymmetry in the rate of VF loss of eyes with
POAG and PACG, we compared these two groups using the
GEE model. Figure 9 shows the comparisons of superior-
inferior asymmetry in the rate of VF loss between eyes with
POAG and PACG, with VF sequences of length 6 to 10, in all
GHT regions (each curve represents rate of VF loss in the
superior region minus that in the inferior region). In eyes with
POAG, the rate of VF loss was always faster in the superior
hemifield than in the inferior hemifield (suggested by negative
values, purple curve). In contrast, eyes with PACG had a faster
rate of VF loss in the inferior hemifield than the superior
hemifield, except in the central region (green curve) when
analyzing VF sequences of length 6 to 10.
To investigate the significance of these differences, we
accounted for gender, maximum IOP, visual acuity, length of
follow-up, and refractive error covariates in the GEE model and
determined that the difference between the asymmetry in the
rates of VF loss between POAG and PACG eyes was statistically
significant in the paracentral region (P¼ 0.03, GEE model) and
peripheral arcuate 2 region (P¼0.04, GEE model). However, in
none of the regions was the extent of asymmetry in the rate of
VF loss different between eyes with POAG and PACG after
adjusting for multiple observations using Bonferroni correc-
tion.
Using VF Sequences With All Visits. To identify the
extent of the asymmetry in the rate of VF loss of eyes with
POAG and PACG, we compared these two groups using GEE
model of the rates of VF loss using sequences with all visits. We
observed that eyes with POAG had significantly faster rate of
VF loss in the paracentral regions of the superior hemifield
than inferior hemifield (P¼ 0.04, GEE model). However, there
was no significant asymmetry in the rate of VF loss in the GHT
regions of eyes with PACG.
We also observed that there was a significant difference
between the extent of asymmetry in the rate of VF loss in eyes
with POAG and PACG in only the paracentral region of GHT (P
¼ 0.03, GEE model).
Between-Group Comparison (Extent of
Asymmetry in POAG Versus PACG) Using Matched
Groups
We repeated the between-group comparison using 75 eyes
with POAG and 75 eyes with PACG in the resampled dataset
(matched for length of follow-up and age). The P values of the
difference between the parameters of eyes with POAG and
PACG for the length of follow-up, age, gender, visual accuity,
maximum IOP, and refractive error were 0.47, 0.30. 0.62, 0.17,
0.93, and <0.001, respectively (using GEE models). Similar to
the initial analysis above, we observed that there was a
significant difference between the extent of asymmetry in the
rate of VF loss of eyes with POAG and PACG in the paracentral
region of GHT (P ¼ 0.04, GEE model).
FIGURE 5. Superior-inferior asymmetry in the rate of VF loss in eyes with POAG (top panel) and PACG (bottom panel) at VF sequences of length 6
to 10. In eyes with POAG (top panel), GHT central and paracentral regions in the superior hemifield had frequently significantly faster rates of VF
loss compared to their counterparts in the inferior hemifield. To the contrary, in eyes with PACG (bottom panel), there was no significant
asymmetry in the rate of VF loss in any region of any VF sequence.
FIGURE 6. Superior-inferior asymmetry in the rate of VF loss in eyes
with POAG (left panel) and PACG (right panel) using VF sequences
with all visits. In eyes with POAG (left panel), GHT central and
peripheral arcuate 2 regions in the superior hemifield had significantly
faster rates of VF loss compared to their counterparts in the inferior
hemifield. However, in eyes with PACG (right panel), there was no
significant asymmetry in the rate of VF loss in any region of any VF
sequence.
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DISCUSSION
In the current study, VF records were collected from 440 eyes
with POAG and 79 eyes with PACG, with at least six reliable
VFs, and global and the superior-inferior asymmetry in the
rates of VF loss were examined region-wise and point-wise.
There was no significant difference in the mTD progression
rates between POAG and PACG eyes. Despite the similar mTD
values at baseline for POAG and PACG eyes, there was a
significant superior-inferior asymmetry in the rate of VF loss in
the GHT central, paracentral, and arcuate 2 regions (faster rate
of VF loss in the superior hemifield than in the inferior
hemifield) of eyes with POAG. In contrast, asymmetry was not
observed in eyes with PACG. Therefore, an asymmetric rate of
VF loss in central, paracentral, and arcuate 2 regions seems to
be a feature of POAG and not PACG.
While the rate of VF loss in POAG eyes,41–52 as well as
differences between the patterns of VF loss in POAG and PACG
eyes,27,30,34,53 has been reported previously, this is, to our
knowledge, the first study directly investigating the differences
in the rate of VF loss as well as the superior-inferior asymmetry
between POAG and PACG eyes with automated perimetry. Lee
and colleauges compared the rate of VF loss using the
Goldmann perimetry; however, their relatively small number
of eyes (25 POAG eyes and 23 PACG eyes) makes the
comparison challenging.54 In the current study, comparison
was made using a larger number of eyes (440 POAG eyes and
79 PACG eyes).
We observed a greater number of females in the PACG
group than in the POAG group (see the Table), which is in
agreement with previous studies suggesting that females are
more likely to develop PACG,8,29,55,30 and gender is even an
independent risk factor for developing PACG.12
In the current study, VFs were collected only prior to laser
iridotomy or cataract surgery in the eyes with PACG, excluding
those with prior acute-angle closure attack; nonetheless, the
progression rates were slow both in POAG (0.23 dB/y) and
PACG eyes (0.29 dB/y) without a significant difference
between the two groups (Fig. 3). Similar slow progression
rates were reported in the study by De Moraes and
colleagues56: the mean rate of VF loss of 0.48 and 0.39
dB/y in POAG and PACG eyes, respectively. Verma and
colleagues36 reported even slower progression rate in PACG
eyes (0.12 dB/y).56 There are other previous studies that
reported faster rates of progression in PACG eyes compared to
POAG eyes, and hence PACG has a threefold greater risk of
developing blindness compared to POAG.2,4,6,25,26 The slow
rate of progression in PACG eyes in the current study could be
due to the fact that these subjects were patients with
controlled glaucoma under treatment in a hospital setting.
Thus, different results could be obtained if eyes with a history
of an angle-closure attack are analyzed. Also, active chronic
PACG eyes, in which intermittent high IOP is observed, is also
problematic, but it is unlikely the current study included these
eyes because the VF data were collected at hospital settings,
and such eyes were treated with laser iridotomy or cataract
surgery without delay. Indeed, low maximum IOP value was
observed in eyes with PACG (14.0 mm Hg on average), which
was lower than that in POAG eyes (16.0 mm Hg on average; see
the Table).
In the current study, several VF sequence lengths, from 6 to
10 visits, were analyzed (see Fig. 2). As can be seen in Figure 5,
the superior-inferior asymmetry in the rate of VF loss (faster in
the superior hemifield than in the inferior hemifield) was not
observed in POAG eyes when short series of VFs (up to seven)
were used. In contrast, the superior-inferior asymmetry in the
rate of VF loss became obvious when longer series of VFs were
used. This is probably due to VF variability and measurement
noise leading to undetectable progression information in
FIGURE 8. Point-wise comparison of the asymmetry in the rate of VF
loss in eyes with POAG and PACG using VF sequences with all visits. In
POAG (left), significant superior-inferior asymmetry in the rate of VF
loss (faster progression rate in the superior hemifield than inferior
hemifield) was observed in the test locations located in the central and
peripheral arcuate 2 regions. In PACG (right), only one test location in
the central region had significant superior-inferior asymmetry in the
rate of VF loss.
FIGURE 7. Point-wise comparison of the asymmetry in the rate of VF loss in eyes with POAG and PACG at VF sequences of length 6 to 10. In eyes
with POAG (top panel), significant superior-inferior asymmetry in the rate of VF loss (faster progression rate in the superior hemifield than inferior
hemifield) was observed more frequently in the test locations located in the central and paracentral regions. In eyes with PACG (bottom panel),
there was no test location that frequently appeared with significant superior-inferior asymmetry in the rate of VF loss.
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analyses with small numbers of VFs. This is in agreement with
previous studies that suggested obtaining a considerable
number of VF tests (e.g., eight VF tests) when assessing
progression.57–60 Moreover, it has been reported that VF
sequence length affects the sensitivity to the progression rate
changes in the trend analysis.61
In the current study, a significant superior-inferior asymme-
try in the rate of VF loss was observed in POAG in both
analyses, whereas this finding was not observed in PACG eyes;
more specifically, in POAG eyes, the superior central and
paracentral had a faster rate of VF loss compared to
corresponding inferior regions based on the analysis with
different numbers of VF sequences (Figs. 5, 6). When we
repeated the analysis using all VF sequences with all visits from
eyes with POAG and PACG, we observed that the superior
central and peripheral arcuate 2 had a faster rate of VF loss
compared to corresponding inferior regions. This was consis-
tent with our point-wise analysis (see Fig. 6). Supporting this,
the comparison between POAG and PACG eyes, using all VF
sequences, revealed a significantly faster progression in the
paracentral region in the superior hemiflield than that in the
inferior hemifield. A possible caveat was that including VF
sequences with larger numbers of visits results in smaller
subject population, which may affect the power of statistical
analysis, in particular for eyes with PACG. To address this
possible concern, we resampled both POAG and PACG eyes so
that the number and other backgrounds were matched
between the two groups. As a result, the superior-inferior
asymmetry in the rate of VF loss was confirmed in the
paracentral region of GHT.
Several studies have shown a significant difference in the
spatial patterns of VF defects between eyes with POAG and
PACG using cross-sectional VF data.27–30 For instance, Gazzard
et al.28 reported that the superior hemifield was more
depressed than in the inferior hemifield in eyes with POAG
and PACG; however, this tendency was much more obvious in
eyes with POAG. This fact corroborates our findings of the
faster rate of VF loss in eyes with POAG than in eyes with PACG
in multiple regions in the superior hemifield. We also found
that only the central region of the superior hemifield of eyes
with PACG had a faster progression rate than that in the
inferior hemifield (although not statistically significant; see Fig.
7). This may also corroborate the results by Gazzard et al.,28
indicating the central region in the superior hemifield is more
pronounced than the inferior hemifield in eyes with PACG.
These results are also supported by many previous studies that
have suggested that VF damage at baseline is a risk factor for
progression.20,62,63
As a limitation of the current study, the follow-up length of
PACG eyes was shorter than that of POAG eyes for given number
of VFs, which may have biased the current results. Also, the
number of PACG eyes (79 eyes) was smaller than the number of
POAG eyes (440 eyes). Therefore, not observing a significant
superior-inferior asymmetry in PACG eyes (Figs. 5, 6) may be
biased in this aspect. However, this effect would be marginal
because a similar result was obtained in the comparison
between POAG and PACG eyes. Moreover, there is a slight
trend to asymmetry in the opposite direction of the PACG eyes
(the inferior hemifield faster than the superior hemifield; Fig. 7).
Nevertheless, our supplemental analysis of selecting a subset of
POAG eyes matched with PACG eye confirmed that the extent
of asymmetry in the rate of VF loss in the paracentral region is
statistically significantly different between eyes with POAG and
PACG. Also, in the current study, only the VF records prior to
laser iridotomy or cataract surgery were included for analysis
with the PACG eyes. Different results may be observed in eyes
with PACG after laser iridotomy or cataract surgery, which
should be investigated in a separate study.
In conclusion, in eyes with POAG, the rate of VF loss was
faster in superior hemifield than in inferior hemifield,
particularly in central, paracentral, and peripheral arcuate 2
regions. This finding was not observed in PACG eyes. This
FIGURE 9. The extent of asymmetry in the rate of VF loss in eyes with POAG and PACG in each GHT region. The difference was calculated by
subtracting the regional rate of TD values in the inferior hemifield from that in the superior hemifield. Panels from left to right correspond to
central, paracentral, nasal, peripheral arcuate 1, and peripheral arcuate 2 regions of GHT. While eyes with POAG had a faster rate of VF loss in the
superior hemifield than in the inferior hemifield, eyes with PACG had a faster rate of VF loss in the inferior hemifield than in the superior hemifield
(except in the central region).
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novel finding could further promote our understanding of
mechanisms underlying both glaucoma types.
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